Who is sponsoring NCT06157411?

NCT06157411 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT06157411?

Interventions in NCT06157411: Mindful Eating Intervention (AC group), Conventional Dietetic Intervention (DC group).

What condition does NCT06157411 study?

NCT06157411 studies Overweight and Obesity.

Is NCT06157411 still recruiting?

NCT06157411 is currently completed. Last updated 22 December 2025.

Last reviewed 2025-12-22 · How we verify

NCT06157411: MIND-EAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adapting Mindful Eating Program for French Overweight/Obese Population

Completed NA Last updated 22 December 2025

What this trial tests

NA trial testing Mindful Eating Intervention (AC group) in Overweight and Obesity in 56 participants. Completed in 10 January 2025.

Timeline

16 February 2024

Primary endpoint
10 January 2025

10 January 2025

Quick facts

Lead sponsor	University Hospital, Montpellier
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	56
Start date	16 February 2024
Primary completion	10 January 2025
Estimated completion	10 January 2025
Sites	1 location across France

Drugs / interventions tested

Mindful Eating Intervention (AC group)
Conventional Dietetic Intervention (DC group)

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to validate a new mindful eating programme adapted to the overweight or obese French population. Recognising the importance of diet in the management of chronic diseases, particularly obesity, and the limitations of traditional weight management approaches, the study focuses on the application of mindful eating. The investigators have adapted a model based on an existing eating disorders programme overseas, taking into account feedback from participants in a qualitative study and the scientific literature. The ultimate aim is to test and validate the effectiveness of this new programme in improving the care of overweight or obese French adults, thereby filling a gap in interventions for this population in France.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The mind-eat program leads to greater improvements in mindful, emotional, and external eating compared to intuitive eating-oriented education in adults with overweight or obesity: a randomized controlled trial.
Van Beekum M, Rodhain A, Shankland R, Chetouane S, et al · · 2026 · PMID 42163359 · DOI 10.1186/s12966-026-01931-y
The Mind-Eat Program Improves Mindful Eating and Related Behaviors in Adults with Overweight or Obesity: A Randomized Controlled Trial
Beekum MV, Rodhain A, Shankland R, Chetouane S, et al · · 2025 · DOI 10.21203/rs.3.rs-7456763/v1

Verify or expand the search:

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06157411 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 22 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06157411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing